Prominent evidence draws attention to significant disturbances in the regulation of the cardiovascular system by Ang II, Ang-(1-7), and AVP in cardiovascular and metabolic disorders, especially when these diseases coexist. This evidence concerns the gene AVP and metabolic disease.